The acute shortage of human organs for transplantation has stimulated exploration into the possibility of using non-human donor organs for xenotransplantation. Pigs are now regarded as the most likely species to serve as donors for clinical xenotransplantation. The first major immunological barrier to overcome to allow successful xenotransplantation is rejection by antibodies present in humans that are directed toward the carbohydrate epitope Galalpha1-3Galbeta1-4G1cNAc-R, (alphaGal) on porcine tissues. A mouse model has been developed in this laboratory to test whether the establishment of molecular chimerism through genetic engineering of bone marrow can prevent production of alphaGal reactive antibodies. Knockout mice (GT0 mice) lacking the gene encoding alpha(1-3)galactosyltransferase (alphaGT) develop serum antibodies reactive against alphaGal. Bone marrow cells harvested from GT0 mice were infected with retroviruses carrying the gene encoding porcine alphaGT, or control viruses carrying only the neomycin (NEO) resistance gene. Lethally-irradiated (10.25Gy) GT0 mice were then reconstituted with either alphaGT or NEO transduced BMC. While control mice reconstituted with NEO transduced BM developed alphaGal reactive serum antibodies, mice receiving alphaGT transduced BMC did not develop alphaGal reactive antibodies over a 25 week follow-up period. These results suggest that expression of a retrovirally transduced alphaGT gene in bone marrow derived cells may prevent the generation of B cells producing alphaGal reactive antibodies.
The specific aims are to: 1) Determine the long-term effect of genetic engineering of bone marrow on production of alphaGal reactive antibodies, and whether the establishment of molecular chimerism is sufficient to prevent humoral rejection of transplanted organs; and 2) Determine the mechanism by which expression of the retrovirally transduced alphaGT gene in bone marrow derived cells prevents development of alphaGal reactive antibodies. These studies should provide practical information important for the field of xenotransplantation, the application of gene therapy to induce B cell tolerance, and may also advance our understanding of self-nonself discrimination in shaping the B cell repertoire. Furthermore, these studies may generally applicable for re-establishing B cell tolerance in auto-immune individuals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI044268-01
Application #
2747672
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Prasad, Shiv A
Project Start
1999-02-15
Project End
2004-01-31
Budget Start
1999-02-15
Budget End
2000-01-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Benatuil, Lorenzo; Kaye, Joel; Cretin, Nathalie et al. (2008) Ig knock-in mice producing anti-carbohydrate antibodies: breakthrough of B cells producing low affinity anti-self antibodies. J Immunol 180:3839-48
Tian, Chaorui; Ansari, Mohammed Javeed I; Paez-Cortez, Jesus et al. (2007) Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy. J Immunol 179:6762-9
Bagley, Jessamyn; Tian, Chaorui; Iacomini, John (2007) New approaches to the prevention of organ allograft rejection and tolerance induction. Transplantation 84:S38-41
Benatuil, Lorenzo; Kaye, Joel; Rich, Robert F et al. (2005) The influence of natural antibody specificity on antigen immunogenicity. Eur J Immunol 35:2638-47
Tian, Chaorui; Bagley, Jessamyn; Cretin, Nathalie et al. (2004) Prevention of type 1 diabetes by gene therapy. J Clin Invest 114:969-78
Kaye, Joel; Bagley, Jessamyn; Malkowski, Denise et al. (2004) The role of complement receptors in production of antibodies specific for Galalpha1,3Gal. Transplantation 77:314-6
Tian, Chaorui; Bagley, Jessamyn; Kaye, Joel et al. (2003) Induction of T cell tolerance to a protein expressed in the cytoplasm through retroviral-mediated gene transfer. J Gene Med 5:359-65
Bagley, J; Iacomini, J (2003) Gene therapy progress and prospects: gene therapy in organ transplantation. Gene Ther 10:605-11
Cretin, Nathalie; Iacomini, John (2002) Immunoglobulin heavy chain transgenic mice expressing Galalpha(1,3)Gal-reactive antibodies. Transplantation 73:1558-64
Bagley, Jessamyn; Iacomini, John (2002) Tracking and selection of retrovirally transduced murine bone marrow cells using green fluorescent protein. Methods Mol Biol 183:309-20

Showing the most recent 10 out of 18 publications